Avid Bioservices Inc (CDMO)

[biopharm]

Must See Presentation..Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL : .

Ok we know Peregrine has already proven PS Targeting reduces MDSCs by at least 40% and here is another late comer talking about MDSCs .....listen to the 6min - 7min mark...

Seems like MDSCs are important to reduce!! Ronin group, you hear this ???


Published Online: Tuesday, Aug 15, 2017
http://www.onclive.com/peer-exchange/strategies-in-kidney-cancer/emerging-immunotherapy-combinations-in-kidney-cancer